nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimonabant—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.785	1	CbGbCtD
Rimonabant—Upset stomach—Riluzole—amyotrophic lateral sclerosis	0.0138	0.0651	CcSEcCtD
Rimonabant—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.0133	0.0626	CcSEcCtD
Rimonabant—Delusion—Riluzole—amyotrophic lateral sclerosis	0.0128	0.0603	CcSEcCtD
Rimonabant—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.00904	0.0427	CcSEcCtD
Rimonabant—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00698	0.033	CcSEcCtD
Rimonabant—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00641	0.0303	CcSEcCtD
Rimonabant—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00621	0.0294	CcSEcCtD
Rimonabant—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00567	0.0268	CcSEcCtD
Rimonabant—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00544	0.0257	CcSEcCtD
Rimonabant—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00506	0.0239	CcSEcCtD
Rimonabant—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00506	0.0239	CcSEcCtD
Rimonabant—Depression—Riluzole—amyotrophic lateral sclerosis	0.00504	0.0238	CcSEcCtD
Rimonabant—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00474	0.0224	CcSEcCtD
Rimonabant—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00452	0.0213	CcSEcCtD
Rimonabant—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00452	0.0213	CcSEcCtD
Rimonabant—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00446	0.0211	CcSEcCtD
Rimonabant—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00412	0.0194	CcSEcCtD
Rimonabant—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00409	0.0193	CcSEcCtD
Rimonabant—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00398	0.0188	CcSEcCtD
Rimonabant—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00395	0.0187	CcSEcCtD
Rimonabant—Tension—Riluzole—amyotrophic lateral sclerosis	0.00388	0.0183	CcSEcCtD
Rimonabant—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00384	0.0181	CcSEcCtD
Rimonabant—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.0038	0.0179	CcSEcCtD
Rimonabant—Tremor—Riluzole—amyotrophic lateral sclerosis	0.0037	0.0175	CcSEcCtD
Rimonabant—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00342	0.0162	CcSEcCtD
Rimonabant—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00335	0.0158	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00334	0.0158	CcSEcCtD
Rimonabant—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00329	0.0155	CcSEcCtD
Rimonabant—Infection—Riluzole—amyotrophic lateral sclerosis	0.0032	0.0151	CcSEcCtD
Rimonabant—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00316	0.0149	CcSEcCtD
Rimonabant—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00313	0.0148	CcSEcCtD
Rimonabant—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00312	0.0147	CcSEcCtD
Rimonabant—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00307	0.0145	CcSEcCtD
Rimonabant—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00292	0.0138	CcSEcCtD
Rimonabant—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.0029	0.0137	CcSEcCtD
Rimonabant—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.0028	0.0132	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00278	0.0131	CcSEcCtD
Rimonabant—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00278	0.0131	CcSEcCtD
Rimonabant—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00264	0.0125	CcSEcCtD
Rimonabant—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00255	0.012	CcSEcCtD
Rimonabant—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00231	0.0109	CcSEcCtD
Rimonabant—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00228	0.0108	CcSEcCtD
Rimonabant—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00221	0.0104	CcSEcCtD
Rimonabant—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00213	0.0101	CcSEcCtD
Rimonabant—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00205	0.00968	CcSEcCtD
Rimonabant—Rash—Riluzole—amyotrophic lateral sclerosis	0.00203	0.0096	CcSEcCtD
Rimonabant—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00203	0.00959	CcSEcCtD
Rimonabant—Headache—Riluzole—amyotrophic lateral sclerosis	0.00202	0.00954	CcSEcCtD
Rimonabant—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00192	0.00905	CcSEcCtD
Rimonabant—CNR1—N-cadherin signaling events—GRIA2—amyotrophic lateral sclerosis	0.000383	0.114	CbGpPWpGaD
Rimonabant—CNR1—N-cadherin signaling events—DCTN1—amyotrophic lateral sclerosis	0.000338	0.101	CbGpPWpGaD
Rimonabant—CNR1—BDNF signaling pathway—PTPRF—amyotrophic lateral sclerosis	0.000212	0.0634	CbGpPWpGaD
Rimonabant—CNR1—BDNF signaling pathway—GRIA2—amyotrophic lateral sclerosis	0.000126	0.0377	CbGpPWpGaD
Rimonabant—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—amyotrophic lateral sclerosis	0.000101	0.0302	CbGpPWpGaD
Rimonabant—CYP2D6—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	9.45e-05	0.0282	CbGpPWpGaD
Rimonabant—CNR1—BDNF signaling pathway—MAPT—amyotrophic lateral sclerosis	9.02e-05	0.0269	CbGpPWpGaD
Rimonabant—CNR2—G alpha (i) signalling events—C5AR1—amyotrophic lateral sclerosis	8.93e-05	0.0267	CbGpPWpGaD
Rimonabant—CYP1A2—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	8.01e-05	0.0239	CbGpPWpGaD
Rimonabant—CNR1—BDNF signaling pathway—SQSTM1—amyotrophic lateral sclerosis	7.12e-05	0.0213	CbGpPWpGaD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	7.1e-05	0.0212	CbGpPWpGaD
Rimonabant—CNR1—G alpha (i) signalling events—C5AR1—amyotrophic lateral sclerosis	7.01e-05	0.0209	CbGpPWpGaD
Rimonabant—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	6.73e-05	0.0201	CbGpPWpGaD
Rimonabant—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	5.75e-05	0.0172	CbGpPWpGaD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	5.57e-05	0.0166	CbGpPWpGaD
Rimonabant—CNR2—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	5.41e-05	0.0161	CbGpPWpGaD
Rimonabant—CNR1—BDNF signaling pathway—BDNF—amyotrophic lateral sclerosis	5.36e-05	0.016	CbGpPWpGaD
Rimonabant—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	4.44e-05	0.0132	CbGpPWpGaD
Rimonabant—CNR1—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	4.24e-05	0.0127	CbGpPWpGaD
Rimonabant—CNR2—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	3.9e-05	0.0116	CbGpPWpGaD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	3.1e-05	0.00926	CbGpPWpGaD
Rimonabant—CNR1—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	3.06e-05	0.00914	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	3.06e-05	0.00913	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	2.78e-05	0.00829	CbGpPWpGaD
Rimonabant—CNR1—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	2.68e-05	0.008	CbGpPWpGaD
Rimonabant—CYP2D6—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	2.48e-05	0.00739	CbGpPWpGaD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	2.43e-05	0.00726	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	2.4e-05	0.00716	CbGpPWpGaD
Rimonabant—CNR2—GPCR ligand binding—C3—amyotrophic lateral sclerosis	2.36e-05	0.00705	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	2.18e-05	0.0065	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	2.16e-05	0.00646	CbGpPWpGaD
Rimonabant—CYP1A2—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	2.1e-05	0.00626	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	2.03e-05	0.00607	CbGpPWpGaD
Rimonabant—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.93e-05	0.00576	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	1.93e-05	0.00576	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	1.87e-05	0.00558	CbGpPWpGaD
Rimonabant—CNR1—GPCR ligand binding—C3—amyotrophic lateral sclerosis	1.85e-05	0.00553	CbGpPWpGaD
Rimonabant—CYP2D6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	1.76e-05	0.00526	CbGpPWpGaD
Rimonabant—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	1.75e-05	0.00521	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	1.7e-05	0.00507	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.66e-05	0.00495	CbGpPWpGaD
Rimonabant—CYP1A2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.65e-05	0.00492	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.64e-05	0.0049	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	1.6e-05	0.00477	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	1.51e-05	0.00452	CbGpPWpGaD
Rimonabant—CYP1A2—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	1.49e-05	0.00446	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	1.47e-05	0.00438	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.37e-05	0.00409	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	1.34e-05	0.00401	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.33e-05	0.00398	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.3e-05	0.00389	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.29e-05	0.00384	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	1.23e-05	0.00367	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.21e-05	0.00362	CbGpPWpGaD
Rimonabant—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	1.15e-05	0.00344	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	1.15e-05	0.00343	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	1.14e-05	0.00341	CbGpPWpGaD
Rimonabant—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	1.14e-05	0.00341	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.13e-05	0.00336	CbGpPWpGaD
Rimonabant—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	1.09e-05	0.00325	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.08e-05	0.00321	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	1.07e-05	0.00321	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.06e-05	0.00315	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	1.05e-05	0.00314	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.05e-05	0.00313	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.01e-05	0.003	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	9.93e-06	0.00297	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	9.77e-06	0.00292	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	9.5e-06	0.00284	CbGpPWpGaD
Rimonabant—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	9.29e-06	0.00278	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	9.18e-06	0.00274	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	8.84e-06	0.00264	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.61e-06	0.00257	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	8.29e-06	0.00248	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.1e-06	0.00242	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	7.89e-06	0.00236	CbGpPWpGaD
Rimonabant—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	7.88e-06	0.00235	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	7.83e-06	0.00234	CbGpPWpGaD
Rimonabant—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	7.81e-06	0.00233	CbGpPWpGaD
Rimonabant—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	7.77e-06	0.00232	CbGpPWpGaD
Rimonabant—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	7.71e-06	0.0023	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	7.37e-06	0.0022	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.16e-06	0.00214	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.76e-06	0.00202	CbGpPWpGaD
Rimonabant—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	6.68e-06	0.00199	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.66e-06	0.00199	CbGpPWpGaD
Rimonabant—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	6.58e-06	0.00197	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.35e-06	0.0019	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	6.29e-06	0.00188	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	6.04e-06	0.0018	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	6.04e-06	0.0018	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	5.99e-06	0.00179	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	5.99e-06	0.00179	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.61e-06	0.00168	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	5.58e-06	0.00167	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	5.52e-06	0.00165	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.5e-06	0.00164	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	5.48e-06	0.00164	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.23e-06	0.00156	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	5.15e-06	0.00154	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.13e-06	0.00153	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	5.12e-06	0.00153	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	5.12e-06	0.00153	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.09e-06	0.00152	CbGpPWpGaD
Rimonabant—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	5.08e-06	0.00152	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	4.83e-06	0.00144	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	4.79e-06	0.00143	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	4.77e-06	0.00142	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	4.68e-06	0.0014	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	4.37e-06	0.0013	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.35e-06	0.0013	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	4.33e-06	0.00129	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.32e-06	0.00129	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.24e-06	0.00127	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	4.09e-06	0.00122	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4e-06	0.0012	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	3.95e-06	0.00118	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	3.95e-06	0.00118	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	3.7e-06	0.0011	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	3.61e-06	0.00108	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.6e-06	0.00107	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.36e-06	0.001	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.32e-06	0.000993	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	3.31e-06	0.000988	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	3.28e-06	0.00098	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	3.16e-06	0.000943	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.14e-06	0.000938	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	3.05e-06	0.000912	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	3.03e-06	0.000904	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	2.85e-06	0.000852	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.82e-06	0.000843	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	2.8e-06	0.000837	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.76e-06	0.000823	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.72e-06	0.000811	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	2.59e-06	0.000773	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	2.51e-06	0.000749	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	2.49e-06	0.000742	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.36e-06	0.000704	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.27e-06	0.000677	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	2.16e-06	0.000646	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.13e-06	0.000637	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	2.12e-06	0.000634	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	2e-06	0.000596	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.94e-06	0.000579	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	1.64e-06	0.00049	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.55e-06	0.000464	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.35e-06	0.000402	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.34e-06	0.000399	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.33e-06	0.000397	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.24e-06	0.00037	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.23e-06	0.000367	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.14e-06	0.000341	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.05e-06	0.000313	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	1.02e-06	0.000304	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	1.01e-06	0.000302	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.81e-07	0.000263	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	8.63e-07	0.000258	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.1e-07	0.000242	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.98e-07	0.000209	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.92e-07	0.000207	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	6.66e-07	0.000199	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.91e-07	0.000177	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.56e-07	0.000136	CbGpPWpGaD
